ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
ML-004-002 is a multi-center, randomized, double-blind, placebo-controlled study that will
enroll approximately 150 adolescent and adult subjects with ASD